Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CB-30865 selected for further study

April 19, 1996

Onconase development update

April 19, 1996

Immune Response in-licenses gene therapy for brain tumors

April 12, 1996

NT-3 lessens cisplatin toxicity in rats

April 12, 1996

Thalidomide in phase II at NCI for cancer indications

April 12, 1996

Banyu reports synthesis and activity of BE-39907A2

April 12, 1996

Banyu discovers new thioredoxin system inhibitor

April 12, 1996

Isis, Ciba-Geigy evaluate antisense drug in phase I

April 12, 1996

Gastrimmune phase I/II trial completed

April 12, 1996

Seed implant treatment effective in prostate cancer

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...